Skip to main content
InfuSystem Holdings, Inc logo

InfuSystem Holdings, Inc — Investor Relations & Filings

Ticker · INFU ISIN · US45685K1025 LEI · 549300F58N8PHJ4QUI59 US Human health and social work activities
Open in API
Filings indexed 1,013 across all filing types
Latest filing 2026-05-18 Transaction in Own Shar…
Country US United States of America
Listing US INFU

About InfuSystem Holdings, Inc

https://ir.infusystem.com/

InfuSystem Holdings, Inc. is a leading provider of medical equipment and related services, specializing in infusion pumps. The company's offerings encompass the sale and rental of new and pre-owned infusion devices, integrated therapy services, and comprehensive biomedical support, including repair and maintenance. It serves a wide range of healthcare settings such as hospitals, oncology practices, surgery centers, and other alternate site care providers. InfuSystem manages a large fleet of medical devices and delivers local, field-based customer support, operating multiple Centers of Excellence to ensure service quality and technical expertise.

Recent filings

Filing Released Lang Actions
8-K
Transaction in Own Shares Classification · 85% confidence The document is a Form 8-K “Current Report” disclosing “Regulation FD Disclosure” that the company’s Board has approved a stock repurchase program authorizing repurchases of up to $20 million of its common stock. This is an announcement of a share buyback program, fitting the “Transaction in Own Shares” category (code POS) rather than a general regulatory notice. It is not an earnings release, management change, or other report type.
2026-05-18 English
S-8
Regulatory Filings Classification · 85% confidence The document is a Form S-8 registration statement filed with the SEC to register shares under an equity incentive plan. It is a regulatory compliance filing that does not match any of the specific categories (e.g., proxy, earnings release, capital update). Therefore it falls under the fallback category “Regulatory Filings (RNS).”
2026-05-18 English
8-K
Board/Management Information Classification · 92% confidence The document is a Form 8-K current report under the Securities Exchange Act of 1934, and its primary substantive disclosure (Item 5.02) is the election of Beverly Huss as Chairman of the Board following the 2026 Annual Meeting. This is an announcement of a change in the company's board of directors, which falls squarely under the Board/Management Information category (MANG).
2026-05-14 English
10-Q - InfuSystem Holdings, Inc (0001337013) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-08 English
8-K - InfuSystem Holdings, Inc (0001337013) (Filer)
Report Publication Announcement Classification · 87% confidence The document is a Form 8-K current report filed with the SEC. It contains no substantive financial data itself but simply states that the Company has issued a press release reporting its Q1 2026 results and that the press release is furnished as an exhibit. The text is short (<5,000 characters) and merely announces the availability of the earnings press release rather than presenting the earnings themselves. Under the “menu vs. meal” rule, this is an announcement of a report attachment/publication, matching the definition of a Report Publication Announcement (RPA).
2026-05-07 English
8-K - InfuSystem Holdings, Inc (0001337013) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by InfuSystem Holdings, Inc. It announces that the company will disclose its first quarter 2026 financial results on May 7, 2026, and conduct a conference call for investors. The document includes a press release as an exhibit but does not contain the actual financial results or detailed financial statements. The length is 3876 characters, which is relatively short and consistent with an announcement rather than a full report. The document explicitly states it is a Current Report (Form 8-K) and is primarily a notification of an upcoming earnings release and conference call. Therefore, this is an announcement related to financial results, not the results themselves. According to the classification rules, such a document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not contain substantive financial data or the full earnings release.
2026-04-30 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.